I agree to the Terms of Use , Privacy Notice and Cookie Notice.

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

A surge in deals and financings had the industry abuzz heading into this year’s J.P Morgan Healthcare Conference. But some ...

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in ...

Triple-leveraged ETFs aren’t for everyone, but if you believe biotech is about to break out, Direxion Daily S&P Biotech Bull ...

Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.

Depending who you ask, AI-powered coding is either giving software developers an unprecedented productivity boost or churning ...

The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...

Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...